Rs11203203 is Associated with Type 1 Diabetes Risk in Population Pre-screened for High-risk HLA-DR,DQ Genotypes

Overview

Journal Pediatr Diabetes

Publisher Wiley

Specialties Endocrinology
Pediatrics

Date 2012 Jul 11

PMID 22776074

Citations 10

Authors

Kelly Johnson

Randall Wong

Katherine J Barriga

Georgeanna Klingensmith

Anette-G Ziegler

Marian J Rewers

Andrea K Steck

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate UBASH3A (rs11203203) as a predictor of persistent islet autoimmunity (IA) and type 1 diabetes (T1D).

Research Design And Methods: The Diabetes Autoimmunity Study in the Young (DAISY) followed prospectively for development of persistent IA (autoantibodies to insulin, GAD65, IA-2, or ZnT8 on at least two consecutive exams) and diabetes 1715 non-Hispanic white children at increased genetic risk for T1D. The DAISY participants were genotyped for rs11202203 (UBASH3A).

Results: UBASH3A allele A was associated with development of IA [hazard ratio (HR) = 1.46, 95%CI = 1.11-1.91, p = 0.007] and diabetes (HR = 1.84, 95%CI = 1.28-2.64, p = 0.001), controlling for presence of HLA-DR3/4,DQB1*0302 and having a first-degree relative (FDR) with T1D. The UBASH3A AA genotype conferred higher risk of persistent IA (12.7%) and diabetes (6.1%) by age 10 than for AG (7.7 and 3.1%, respectively) or GG (5.3 and 2.0%) genotype (p = 0.009 for IA, p = 0.0004 for diabetes). Among children with no family history of T1D, but HLA-DR3/4,DQB1*0302 and UBASH3A AA genotype, 35.9% developed IA and 50.6% developed diabetes by age 15.

Conclusions: UBASH3A appears to be an independent predictor of IA and T1D in children, including those free of family history of T1D but carrying the HLA-DR3/4,DQB1*0302 genotype. If confirmed, UBASH3A may prove useful in T1D risk prediction and pre-screening of the general population children for clinical trials.

Citing Articles

Type 1 Diabetes Genetic Risk Scores: History, Application and Future Directions.

Tosur M, Onengut-Gumuscu S, Redondo M Curr Diab Rep. 2025; 25(1):22.

PMID: 39920466 DOI: 10.1007/s11892-025-01575-5.

TULA Proteins in Men, Mice, Hens, and Lice: Welcome to the Family.

Tsygankov A Int J Mol Sci. 2023; 24(11).

PMID: 37298079 PMC: 10253181. DOI: 10.3390/ijms24119126.

UBASH3A Interacts with PTPN22 to Regulate Expression and Risk for Type 1 Diabetes.

Newman J, Concannon P, Ge Y Int J Mol Sci. 2023; 24(10).

PMID: 37240014 PMC: 10218450. DOI: 10.3390/ijms24108671.

Gene expression signature predicts rate of type 1 diabetes progression.

Suomi T, Starskaia I, Kalim U, Rasool O, Jaakkola M, Gronroos T EBioMedicine. 2023; 92:104625.

PMID: 37224769 PMC: 10277927. DOI: 10.1016/j.ebiom.2023.104625.

Impact of Zinc Transport Mechanisms on Embryonic and Brain Development.

Willekens J, Runnels L Nutrients. 2022; 14(12).

PMID: 35745255 PMC: 9231024. DOI: 10.3390/nu14122526.

References

Reddy M, Wang H, Liu S, Bode B, Reed J, Steed R . Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun. 2011; 12(3):208-12. PMC: 3952552. DOI: 10.1038/gene.2010.70. View

Noble J, Valdes A, Cook M, Klitz W, Thomson G, Erlich H . The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet. 1996; 59(5):1134-48. PMC: 1914851. View

Barrett J, Clayton D, Concannon P, Akolkar B, Cooper J, Erlich H . Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009; 41(6):703-7. PMC: 2889014. DOI: 10.1038/ng.381. View

Grant S, Qu H, Bradfield J, Marchand L, Kim C, Glessner J . Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes. 2008; 58(1):290-5. PMC: 2606889. DOI: 10.2337/db08-1022. View

Yu L, Rewers M, Gianani R, Kawasaki E, Zhang Y, Verge C . Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab. 1996; 81(12):4264-7. DOI: 10.1210/jcem.81.12.8954025. View

Vang T, Congia M, Macis M, Musumeci L, Orru V, Zavattari P . Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet. 2005; 37(12):1317-9. DOI: 10.1038/ng1673. View

Cooper J, Walker N, Smyth D, Downes K, Healy B, Todd J . Follow-up of 1715 SNPs from the Wellcome Trust Case Control Consortium genome-wide association study in type I diabetes families. Genes Immun. 2009; 10 Suppl 1:S85-94. PMC: 2805462. DOI: 10.1038/gene.2009.97. View

Wattenhofer M, Shibuya K, Kudoh J, Lyle R, Michaud J, Rossier C . Isolation and characterization of the UBASH3A gene on 21q22.3 encoding a potential nuclear protein with a novel combination of domains. Hum Genet. 2001; 108(2):140-7. DOI: 10.1007/s004390000453. View

Begovich A, Carlton V, Honigberg L, Schrodi S, Chokkalingam A, Alexander H . A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004; 75(2):330-7. PMC: 1216068. DOI: 10.1086/422827. View

10.

Bonifacio E, Hummel M, Walter M, Schmid S, Ziegler A . IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care. 2004; 27(11):2695-700. DOI: 10.2337/diacare.27.11.2695. View

11.

Smyth D, Cooper J, Collins J, Heward J, Franklyn J, Howson J . Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes. 2004; 53(11):3020-3. DOI: 10.2337/diabetes.53.11.3020. View

12.

Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M . A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004; 36(4):337-8. DOI: 10.1038/ng1323. View

13.

Todd J, Walker N, Cooper J, Smyth D, Downes K, Plagnol V . Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007; 39(7):857-64. PMC: 2492393. DOI: 10.1038/ng2068. View

14.

Zhernakova A, Stahl E, Trynka G, Raychaudhuri S, Festen E, Franke L . Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet. 2011; 7(2):e1002004. PMC: 3044685. DOI: 10.1371/journal.pgen.1002004. View

15.

. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447(7145):661-78. PMC: 2719288. DOI: 10.1038/nature05911. View

16.

Kyogoku C, Langefeld C, Ortmann W, Lee A, Selby S, Carlton V . Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet. 2004; 75(3):504-7. PMC: 1182029. DOI: 10.1086/423790. View

17.

Rewers M, Bugawan T, Norris J, Blair A, Beaty B, Hoffman M . Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996; 39(7):807-12. DOI: 10.1007/s001250050514. View

18.

Carpino N, Turner S, Mekala D, Takahashi Y, Zang H, Geiger T . Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity. 2004; 20(1):37-46. DOI: 10.1016/s1074-7613(03)00351-0. View

19.

Emery L, Babu S, Bugawan T, Norris J, Erlich H, Eisenbarth G . Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates. Pediatr Diabetes. 2005; 6(3):136-44. PMC: 1351310. DOI: 10.1111/j.1399-543X.2005.00117.x. View

20.

Steck A, Zhang W, Bugawan T, Barriga K, Blair A, Erlich H . Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?. Diabetes. 2009; 58(4):1028-33. PMC: 2661592. DOI: 10.2337/db08-1179. View